| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/02/1999 | US5866127 Vascular permeability factor targeted compounds |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | US5866120 Therapy for vision defects |
| 02/02/1999 | US5866105 Therapy for onychomycosis; topical applying nail varnish |
| 02/02/1999 | CA2182200C Formulations for factor ix |
| 02/02/1999 | CA2169987C Gel form of a vaccine |
| 02/02/1999 | CA2141192C Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
| 02/02/1999 | CA2132347C Liposomes with a negative excess charge |
| 02/02/1999 | CA2130464C Topical aromatic releasing compositions |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/02/1999 | CA2017916C Etoposide preparations |
| 01/29/1999 | CA2211949A1 Nonaqueous compositions for parenteral administration |
| 01/28/1999 | WO1999003871A1 Hexadecasaccharide-protein conjugate vaccine for shigella dysenteriae type 1 |
| 01/28/1999 | WO1999003860A1 Water soluble polymer-tacrolimus conjugated compounds and process for preparing the same |
| 01/28/1999 | WO1999003823A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | WO1999003505A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | WO1999003501A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1999003474A1 Method for producing stable acetylsalicylic acid solutions |
| 01/28/1999 | WO1999003461A1 Oily patches for external use containing diclofenac sodium |
| 01/28/1999 | WO1999003455A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | WO1999003454A1 Biodegradable macromers for the controlled release of biologically active substances |
| 01/28/1999 | WO1999003452A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | WO1999003451A1 Pharmaceutical formulations for oral administration |
| 01/28/1999 | WO1999003450A1 Cross-linked plant protein particles, in particular microparticles or nanoparticles, preparation method and cosmetic, pharmaceutical or food compositions containing same |
| 01/28/1999 | WO1999003449A1 Bright white film coatings and film coating compositions therefor |
| 01/28/1999 | WO1998047530A3 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 01/28/1999 | WO1998045233A3 Omega-amino acid derivatives, processes of their preparation and their use |
| 01/28/1999 | WO1998038984A3 Formulations for hydrophobic pharmaceutical agents |
| 01/28/1999 | WO1998037200A3 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/28/1999 | DE19732139A1 Immobilisierung von Vitamin-A-Säure durch kationische Polyelektrolyte Immobilization of vitamin A acid by cationic polyelectrolytes |
| 01/28/1999 | DE19725766A1 Formulation for immunological test systems and adjuvants |
| 01/28/1999 | CA2298464A1 Method for producing stable acetylsalicylic acid solutions |
| 01/28/1999 | CA2297413A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | CA2297072A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 01/28/1999 | CA2296620A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | CA2296459A1 Biodegradable macromers for the controlled release of biologically active substances |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2294934A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | CA2288204A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/27/1999 | EP0893439A1 Polypeptides modified by carbonates of polyalkylene oxide polymers |
| 01/27/1999 | EP0893125A1 Fine grain carriers and medicinal composition prepared with the use of the same |
| 01/27/1999 | EP0893121A1 Oral liquid medicine solution |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0892636A1 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 01/27/1999 | EP0892632A1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 01/27/1999 | EP0607434B1 Anti-inflammatory analgesic plaster |
| 01/27/1999 | EP0554441B1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 01/27/1999 | EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/27/1999 | CN1206347A Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 01/27/1999 | CN1041799C Preparation of thrombolytic composition |
| 01/27/1999 | CN1041797C Tablets with improved bioavailability of active material clodronic acid |
| 01/27/1999 | CN1041795C Ophthalmological preparation |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/27/1999 | CN1041793C Pharmaceutical composition of florfenicol |
| 01/26/1999 | US5863990 Biodegradable polyacetal polymers and methods for their formation and use |
| 01/26/1999 | US5863953 Liquid, oil-miscible carotenoid preparations |
| 01/26/1999 | US5863944 Compounds and compositions for delivering active agents |
| 01/26/1999 | US5863942 Retinoid conjugate compounds useful for the treatment of aging skin |
| 01/26/1999 | US5863919 Lock and key micelles and monomer building blocks therefor |
| 01/26/1999 | US5863908 Carboxymethylmannoglucans and derivatives thereof |
| 01/26/1999 | US5863907 Carboxymethylmannoglucans and derivatives thereof |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863900 Lhrh antagonists |
| 01/26/1999 | US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis |
| 01/26/1999 | US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment |
| 01/26/1999 | US5863562 Methods and composition for preserving media in the tip of a solution dispenser |
| 01/26/1999 | US5863560 Compositions and methods for topical application of therapeutic agents |
| 01/26/1999 | US5863559 Oral dosage form for treating migraine |
| 01/26/1999 | US5863558 Administering a controlled release antiepileptic drug wherein the dosage form comprising a nonionic protective film for protecting from fluid of the gastrointestinal environment |
| 01/26/1999 | US5863553 Bioerodible contraceptive suppository |
| 01/26/1999 | US5863549 Methods for the sustained release of biologically active compounds |
| 01/26/1999 | US5863544 Consists of hydroxy acid, polysiloxane and polyol alkyl ester; useful for therapeutical treatment of acne, mycosis, seborrhoeic dermatitis, eczema, rosacea, cutaneous aging or scalp or nail maladies |
| 01/26/1999 | US5863538 Compositions for targeting the vasculature of solid tumors |
| 01/26/1999 | US5863520 Images for medical diagnosis of organs |
| 01/26/1999 | US5863518 Diagnostic imaging agent with backbone with modified sugar chain end |
| 01/26/1999 | CA2140032C Cross-linked amylose material for enzymatically controlled drug release |
| 01/26/1999 | CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| 01/26/1999 | CA2137573C Pharmaceutical compositions containing nsaid and bile acids |
| 01/26/1999 | CA2136843C Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 01/26/1999 | CA2059865C Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 01/25/1999 | CA2243827A1 Veterinary composition for treating epidermal irritations |
| 01/23/1999 | CA2243394A1 Methods and compositions for fine lines and/or wrinkles |
| 01/21/1999 | WO1999002665A1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002647A2 Cloning vectors for producing adenoviral minimal viruses |
| 01/21/1999 | WO1999002567A2 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002252A1 Improvements in or relating to capsules |
| 01/21/1999 | WO1999002191A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 01/21/1999 | WO1999002186A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | WO1999002182A2 Non-aqueous vaccines |
| 01/21/1999 | WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | WO1999002177A1 Pharmaceutical composition containing peptichemio |
| 01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | WO1999002158A1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
| 01/21/1999 | WO1999002151A1 Paclitaxel compositions containing hyaluronic acid of a molecular weight of less than 750.000 da |
| 01/21/1999 | WO1999002145A1 Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines |
| 01/21/1999 | WO1999002141A1 Block copolymer |